Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jingfei Teng is active.

Publication


Featured researches published by Jingfei Teng.


BJUI | 2013

Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis: PVP vs TURP for treating BPH

Jingfei Teng; Dong-xu Zhang; Yao Li; Lei Yin; Kai Wang; Xingang Cui; Danfeng Xu

Despite high morbidities, TURP is still considered as the ‘gold standard’ for treatment of BPH. Photoselective vaporization of the prostate (PVP) is a promising technique that is emerging as a possible alternative to TURP. However, there remains some debate about the advantages of PVP over TURP and whether PVP will be able to replace TURP as the first‐line surgical treatment. We conducted a meta‐analysis of recent papers on this subject and herein provide the overall efficacy and safety of PVP for treatment of BPH.


BJUI | 2012

Transrectal sonoelastography in the detection of prostate cancers: a meta-analysis.

Jingfei Teng; Ming Chen; Yi Gao; Yacheng Yao; Lu Chen; Danfeng Xu

Study Type – Diagnostic (exploratory cohort)


Urologia Internationalis | 2013

Retroperitoneal laparoscopic radical nephrectomy for renal cell carcinoma during pregnancy.

Lei Yin; Dong-xu Zhang; Jingfei Teng; Danfeng Xu

Renal cell carcinoma (RCC) during pregnancy is rare. We present a case of retroperitoneal laparoscopic radical nephrectomy for RCC in a 32-year-old pregnant female. The tumor was excised en bloc. Retroperitoneal laparoscopic radical nephrectomy appears to be a feasible and safe treatment option for RCC in pregnancy.


Medical Oncology | 2015

The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer

Yi Gao; Jingfei Teng; Yi Hong; Fa-Jun Qu; Jizhong Ren; Lin Li; Xiu-Wu Pan; Lu Chen; Lei Yin; Danfeng Xu; Xingang Cui

EIF3 is the largest multi-protein complex, and several studies have revealed the oncogenic roles of its subunits in many human cancers. However, the roles of EIF3D in the development and progression of PCa remain uncovered. In the present study, the expression of EIF3D in prostate cancer and paracarcinoma tissues, as well as PCa cell lines, was examined. In PCa tissues, the expression of EIF3D was up-regulated compared to that in paracarcinoma tissues. In order to investigate whether EIF3D could serve as potential therapeutic target for prostate cancer, EIF3D was knocked down to verify its functional role in prostate cancer cells. After EIF3D knockdown in PC-3 and DU145 cells, cell proliferation, invasion and colony formation were significantly inhibited; meanwhile, cell cycle analysis revealed cell cycle arrest at G2/M phase. EIF3D is associated with PCa, and silencing EIF3D will result in decreased proliferation, and migration, as well as G2/M arrest in DU145 and PC-3 cells. These results suggest that EIF3D plays an oncogenic role in PCa development and progression.


Chinese Medical Journal | 2014

Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.

Jingfei Teng; Gao Y; Minhu Chen; Wang K; Xingang Cui; Yang Liu; Danfeng Xu

Background Surgical resection is the most effective treatment for renal cell carcinoma (RCC). Currently several prognostic factors and models are used for outcome prediction. However, whether intratumoral changes are independent prognostic factors for RCC or not remains unclear. The aim of the study was to investigate the prognostic roles of intratumoral changes in surgical treated localized clear cell renal cell carcinoma (ccRCC). Methods Patients who received partial or radical nephrectomy between 2004 and 2009 in our center were retrospectively reviewed. Univariate and multivariate analyses were used to assess gender, age, body mass index (BMI), intratumoral hemorrhage, tumor necrosis, cystic degeneration, sarcomatoid change, Ki‐67 expression, Fuhrman grade, and T stage on recurrence‐free survival (RFS) and cancer‐specific survival (CSS). Results A total of 378 patients were included in our study. In univariate analysis, age, BMI, intratumoral hemorrhage, tumor necrosis, sarcomatoid change, Ki‐67 expression level, Fuhrman grade, and T stage were prognostic factors for RFS. Age, BMI, tumor necrosis, sarcomatoid change, Ki‐67 expression level, Fuhrman grade, and T stage were prognostic factors effecting CSS. In multivariate analysis, age, BMI, tumor necrosis, sarcomatoid change, Ki‐67, Fuhrman grade, and T stage were independent prognostic factors for both RFS and CSS. Conclusion Intratumoral changes such as tumor necrosis and sarcomatoid change are independent prognostic factors for ccRCC.


Asian Journal of Andrology | 2015

Transurethral plasmakinetic resection of the prostate is a reliable minimal invasive technique for benign prostate hyperplasia: a meta-analysis of randomized controlled trials

Kai Wang; Yao Li; Jingfei Teng; Haiyong Zhou; Danfeng Xu; Yi Fan

To evaluate the efficacy and safety of plasmakinetic resection of the prostate (PKRP) versus transurethral resection of the prostate (TURP) for the treatment of patients with benign prostate hyperplasia (BPH), a meta-analysis of randomized controlled trials was carried out. We searched PubMed, Embase, Web of Science and the Cochrane Library. The pooled estimates of maximum flow rate, International Prostate Symptom Score, operation time, catheterization time, irrigated volume, hospital stay, transurethral resection syndrome, transfusion, clot retention, urinary retention and urinary stricture were assessed. There was no notable difference in International Prostate Symptom Score between TURP and PKRP groups during the 1-month, 3 months, 6 months and 12 months follow-up period, while the pooled Q max at 1-month favored PKRP group. PKRP group was related to a lower risk rate of transurethral resection syndrome, transfusion and clot retention, and the catheterization time and operation time were also shorter than that of TURP. The irrigated volume, length of hospital stay, urinary retention and urinary stricture rate were similar between groups. In conclusion, our study suggests that the PKRP is a reliable minimal invasive technique and may anticipatorily prove to be an alternative electrosurgical procedure for the treatment of BPH.


Urology | 2013

Transperitoneal Laparoscopic Excision of Primary Seminal Vesicle Benign Tumors: Surgical Techniques and Follow-up Outcomes

Dong-xu Zhang; Yao Li; Xun-gang Li; Xian Zhu; Jingfei Teng; Kai Wang; Junkai Wang; Lu Chen; Xingang Cui; Danfeng Xu

OBJECTIVE To assess the feasibility, safety, and efficacy of transperitoneal laparoscopic excision of primary seminal vesicle benign tumors (SVBTs) and summarize our experience with surgical techniques and follow-up outcomes of this rare condition. METHODS This study included 6 patients who underwent transperitoneal laparoscopic excision of primary SVBTs between June 2005 and April 2011. A 5-port transperitoneal approach was used. The ipsilateral vas deferens was identified in the upper bulge of the retrovesical peritoneal reflection through a transverse approach and was dissected inwardly and used as a guide to the seminal vesicle tumor. Endoscopic Hem-o-lok clips (Teleflex Medical) were applied to control the vascular supply to the tumor base. With the contralateral vas deferens and seminal vesicle preserved, the tumor was removed together with the vas deferens and the adjoining ipsilateral seminal vesicle. The surgical procedures were successful in all 6 patients, without conversion to open surgery. The mean duration of surgery was 70 ± 16 minutes (range, 50-100 minutes), with unremarkable blood loss of less than 50 mL. The mean postoperative hospital length of stay was 5.2 ± 1.6 days (range, 4-8 days). No intra- or postoperative complications occurred. During a mean follow-up period of 42 ± 24 months (range, 12-82 months), all patients remained asymptomatic, with preserved function as reported by the patient, and there was no evidence of recurrence. CONCLUSION Our study demonstrated that transperitoneal laparoscopic excision of primary SVBTs is a viable option for minimally invasive treatment of SVBT.


Biomedicine & Pharmacotherapy | 2017

Numb had anti-tumor effects in prostatic cancer

Ji Sun; Kai Wang; Jingfei Teng; Yufu Yu; Runmiao Hua; Haiyong Zhou; Dachuan Zhong; Yi Fan

AIM The aim of this study was to explain the Numb anti-cancer effects in the prostatic cancer. METHODS Collecting the 20 prostatic cancer patients and analyzing the correlation between Numb and Glease score. Transfection Numb into DU-145 and PC-3 cells, measuring the proliferation rate of difference groups by MTT assay, evaluating the cell apoptosis and cell cycle of difference group by Flow cytometry; measuring the invasion and migration abilities by transwell and wound healing assays. In the nude mice experiment, establish prostatic cancer nude mouse subcutaneous planting tumor model by DU-145 cells, Injection the Numb from tail vein. Evaluating the tumor volume and weight. RESULTS The Numb protein expression was decreased with Glease score increasing. The proliferation rate of Numb groups were significantly decreased compared with NC groups (P<0.05, respectively). The apoptosis and G1 phase rates of Numb groups were significantly enhanced compared with NC groups (P<0.05, respectively). The invasion and migration abilities of Numb group cells were significantly weaken compared with NC groups (P<0.05, respectively). In the WB assay, The relative proteins (Numb, P53, Cyclin D1, Rac1, MMP-2 and MMP-9) expression were significantly differences between NC and Numb groups (P<0.05, respectively). In the vivo experiment, the tumor volume and weight of Numb group was significantly lighter than NC group (P<0.05, respectively). CONCLUSION Overexpression Numb had anti-cancer effects to prostatic cancer in vitro and vivo experiments, the mechanism might be P53/Cyclin D1 and Rac1/MMP-2/-9 signaling pathway.


Kaohsiung Journal of Medical Sciences | 2015

A matched-pair comparison of single plus one port versus standard extraperitoneal laparoscopic radical prostatectomy by a single urologist

Dong-xu Zhang; Jingfei Teng; Xiu-Wu Pan; Kai Wang; Xingang Cui; Danfeng Xu; Yao Li; Yi Gao; Lei Yin; Junkai Wang; Lu Chen

We conducted this study to report on our initial experience and assess the safety, feasibility, and efficacy of extraperitoneal single plus one port laparoscopic radical prostatectomy (SPOPL‐RP), and determine whether it shows any objective advantage over standard laparoscopic radical prostatectomy. From June 2009 to September 2011, 15 extraperitoneal SPOPL‐RPs were performed through a 2–3‐cm subumbilical longitudinal incision and another 5‐mm trocar placed at the McBurney point. This cohort was compared with 37 contemporary patients who underwent standard extraperitoneal laparoscopic radical prostatectomy performed by the same urologist. Peri‐ and postoperative outcomes, including continence, potency, and scar length, were statistically analyzed. The two groups were comparable with respect to patient demographics, estimated blood loss, drainage time, duration of catheterization, catheterization rate >14 days, complication rate, postoperative hospitalization, and postoperative functional and oncologic outcomes (p > 0.05). The SPOPL‐RP procedures had a longer mean operative time (170.1 minutes vs. 139.5 minutes, p = 0.005), but with fewer patients requiring analgesics (20% vs. 54.1%, p = 0.038) and earlier resumption of oral intake (20.7 hours vs. 26.8 hours, p = 0.037). The mean scar length in the SPOPL‐RP group was much smaller (3.4 cm vs. 5.8 cm, p = 0.000) owing to the significant reduction of the skin incision. The peri‐ and postoperative outcomes of SPOPL‐RP for low‐risk prostate cancer are comparable to those with the standard laparoscopic approach. In addition, SPOPL‐RP provides better postoperative pain control, faster recovery of bowel function, and smaller scar length than standard laparoscopy, albeit with a longer operative time.


Chinese Medical Journal | 2015

Conditional Knockout of Src Homology 2 Domain-containing Protein Tyrosine Phosphatase-2 in Myeloid Cells Attenuates Renal Fibrosis after Unilateral Ureter Obstruction.

Jingfei Teng; Kai Wang; Yao Li; Fa-Jun Qu; Qing Yuan; Xingang Cui; Quanxing Wang; Danfeng Xu

Background: Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP-2) is a kind of intracellular protein tyrosine phosphatase. Studies have revealed its roles in various disease, however, whether SHP-2 involves in renal fibrosis remains unclear. The aim of this study was to explore the roles of myeloid cells SHP-2 in renal interstitial fibrosis. Methods: Myeloid cells SHP-2 gene was conditionally knocked-out (CKO) in mice using loxP-Cre system, and renal interstitial fibrosis was induced by unilateral ureter obstruction (UUO). The total collagen deposition in the renal interstitium was assessed using picrosirius red stain. F4/80 immunostaing was used to evaluate macrophage infiltration in renal tubular interstitium. Quantitative real-time polymerase chain reaction and enzyme linked immunosorbent assay were used to analyze the production of cytokines in the kidney. Transferase-mediated dUTP nick-end labeling stain was used to assess the apoptotic renal tubular epithelial cells. Results: Src homology 2 domain-containing protein tyrosine phosphatase-2 gene CKO in myeloid cells significantly reduced collagen deposition in the renal interstitium after UUO. Macrophage infiltration was evidently decreased in renal tubular interstitium of SHP-2 CKO mice. Meanwhile, the production of pro-inflammatory cytokines was significantly suppressed in SHP-2 CKO mice. However, no significant difference was observed in the number of apoptotic renal tubular epithelial cells between wild-type and SHP-2 CKO mice. Conclusions: Our observations suggested that SHP-2 in myeloid cells plays a pivotal role in the pathogenesis of renal fibrosis, and that silencing of SHP-2 gene in myeloid cells may protect renal from inflammatory damage and prevent renal fibrosis after renal injury.

Collaboration


Dive into the Jingfei Teng's collaboration.

Top Co-Authors

Avatar

Danfeng Xu

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xingang Cui

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fa-Jun Qu

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Yao Li

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Lei Yin

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Lu Chen

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Yi Gao

Second Military Medical University

View shared research outputs
Top Co-Authors

Avatar

Xiu-Wu Pan

Second Military Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge